There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
England won the Women's World Cup final in the most dramatic fashion against India at Lord's.
Tarek Naggar, 44, is said to be fighting for life after he was attacked during a robbery on the island province of Cebu.
Passengers have been left stranded at Oxford station after someone forgot to unlock the entrance doors